{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:47:58Z","timestamp":1791582478793,"version":"4.3.4"},"reference-count":118,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.kint.2018.10.010","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T09:37:22Z","timestamp":1545989842000},"page":"506-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Emerging role of myostatin and its inhibition in the setting of chronic kidney disease"],"prefix":"10.1016","volume":"95","author":[{"given":"Daniela","family":"Verzola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Barisione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Picciotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-2429","authenticated-orcid":false,"given":"Giacomo","family":"Garibotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5076-2420","authenticated-orcid":false,"given":"Laetitia","family":"Koppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2018.10.010_bib1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1474-9726.2011.00734.x","article-title":"Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-\u03baB","volume":"10","author":"Sriram","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.kint.2018.10.010_bib2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","article-title":"Stat3 activation links a C\/EBP\u03b4 to myostatin pathway to stimulate loss of muscle mass","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.kint.2018.10.010_bib3","doi-asserted-by":"crossref","first-page":"18162","DOI":"10.1073\/pnas.1317049110","article-title":"Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-\u03baB-mediated mechanism","volume":"110","author":"Qiu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2018.10.010_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/JOE-07-0596","article-title":"Angiotensin II activates myostatin expression in cultured rat neonatal cardiomyocytes via p38 MAP kinase and myocyte enhance factor 2 pathway","volume":"197","author":"Wang","year":"2008","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.kint.2018.10.010_bib5","doi-asserted-by":"crossref","first-page":"e0156225","DOI":"10.1371\/journal.pone.0156225","article-title":"Glucocorticoids enhance muscle proteolysis through a myostatin-dependent pathway at the early stage","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.10.010_bib6","doi-asserted-by":"crossref","first-page":"46362","DOI":"10.1038\/srep46362","article-title":"Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment","volume":"7","author":"Verzola","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2018.10.010_bib7","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3389\/fimmu.2017.01747","article-title":"Myostatin promotes interleukin-1\u03b2 expression in rheumatoid arthritis synovial fibroblasts through inhibition of miR-21-5p","volume":"8","author":"Hu","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2018.10.010_bib8","doi-asserted-by":"crossref","first-page":"H1973","DOI":"10.1152\/ajpheart.00200.2011","article-title":"Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting","volume":"300","author":"Breitbart","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.kint.2018.10.010_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.kint.2018.10.010_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/138920207783591672","article-title":"Myostatin in the pathophysiology of skeletal muscle","volume":"8","author":"Carnac","year":"2007","journal-title":"Curr Genomics"},{"key":"10.1016\/j.kint.2018.10.010_bib11","doi-asserted-by":"crossref","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","article-title":"Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size","volume":"296","author":"Trendelenburg","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.kint.2018.10.010_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrneph.2014.112","article-title":"Mechanisms of muscle wasting in chronic kidney disease","volume":"10","author":"Wang","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2018.10.010_bib13","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.biocel.2013.05.019","article-title":"Myostatin\/activin pathway antagonism: molecular basis and therapeutic potential","volume":"45","author":"Han","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.kint.2018.10.010_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/ng0997-71","article-title":"A\u00a0deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle","volume":"17","author":"Grobet","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2018.10.010_bib15","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1101\/gr.7.9.910","article-title":"Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle","volume":"7","author":"Kambadur","year":"1997","journal-title":"Genome Res"},{"key":"10.1016\/j.kint.2018.10.010_bib16","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","article-title":"Myostatin mutation associated with gross muscle hypertrophy in a child","volume":"350","author":"Schuelke","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2018.10.010_bib17","doi-asserted-by":"crossref","first-page":"49831","DOI":"10.1074\/jbc.M204291200","article-title":"Myostatin inhibits myoblast differentiation by down-regulating MyoD expression","volume":"277","author":"Langley","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2018.10.010_bib18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1083\/jcb.200207056","article-title":"Myostatin negatively regulates satellite cell activation and self-renewal","volume":"162","author":"McCroskery","year":"2003","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.kint.2018.10.010_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/JOE-17-0032","article-title":"IGF1 stimulates greater muscle hypertrophy in the absence of myostatin in male mice","volume":"23","author":"Hennebry","year":"2017","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.kint.2018.10.010_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/en.2010-0488","article-title":"Endocrine actions of myostatin: systemic regulation of the IGF and IGF binding protein axis","volume":"152","author":"Williams","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2018.10.010_bib21","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00125-011-2079-7","article-title":"Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway","volume":"54","author":"Zhang","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.kint.2018.10.010_bib22","doi-asserted-by":"crossref","first-page":"e4937","DOI":"10.1371\/journal.pone.0004937","article-title":"Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity","volume":"4","author":"Guo","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.10.010_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.metabol.2014.10.007","article-title":"Over-expression of Follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice","volume":"64","author":"Brandt","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.kint.2018.10.010_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/db08-0943","article-title":"Increased secretion and expression of myostatin in skeletal muscle from extremely obese women","volume":"58","author":"Hittel","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.kint.2018.10.010_bib25","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1249\/MSS.0b013e3182178bb4","article-title":"Expression and function of myostatin in obesity, diabetes, and exercise adaptation","volume":"4","author":"Allen","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.kint.2018.10.010_bib26","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.2337\/db11-0915","article-title":"Myostatin inhibition prevents diabetes and hyperphagia in a mouse model of lipodystrophy","volume":"61","author":"Guo","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.kint.2018.10.010_bib27","doi-asserted-by":"crossref","first-page":"32495","DOI":"10.1038\/srep32495","article-title":"Myostatin inhibition therapy for insulin-deficient type 1 diabetes","volume":"6","author":"Coleman","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2018.10.010_bib28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/07435800.2016.1198802","article-title":"Myostatin and carbohydrate disturbances","volume":"42","author":"Assyov","year":"2017","journal-title":"Endocr Res"},{"key":"10.1016\/j.kint.2018.10.010_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ijo.2015.200","article-title":"Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues","volume":"40","author":"Dong","year":"2016","journal-title":"Int J Obes"},{"key":"10.1016\/j.kint.2018.10.010_bib30","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","article-title":"Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure","volume":"55","author":"Stenvinkel","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.010_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.atherosclerosis.2009.11.016","article-title":"The natural history of aortic atherosclerosis: a systematic histopathological evaluation of the peri-renal region","volume":"210","author":"van Dijk","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.kint.2018.10.010_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis: an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2018.10.010_bib33","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nm.3866","article-title":"KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis","volume":"21","author":"Shankman","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2018.10.010_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apha.12466","article-title":"Vascular smooth muscle cell in atherosclerosis","volume":"214","author":"Chistiakov","year":"2015","journal-title":"Acta Physiol"},{"key":"10.1016\/j.kint.2018.10.010_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tcm.2006.11.001","article-title":"Smoothelin in vascular smooth muscle","volume":"17","author":"van Eys","year":"2007","journal-title":"Cells Trends Cardiovasc Med"},{"key":"10.1016\/j.kint.2018.10.010_bib36","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2741\/4337","article-title":"Chronic kidney disease alters vascular smooth muscle cell phenotype","volume":"20","author":"Monroy","year":"2015","journal-title":"Front Biosci"},{"key":"10.1016\/j.kint.2018.10.010_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.atherosclerosis.2016.12.022","article-title":"Uremia modulates the phenotype of aortic smooth muscle cells","volume":"257","author":"Madsen","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.kint.2018.10.010_bib38","doi-asserted-by":"crossref","first-page":"e71017","DOI":"10.1371\/journal.pone.0071017","article-title":"AAV-mediated administration of myostatin pro-peptide mutant in adult Ldlr null mice reduces diet- induced hepatosteatosis and arteriosclerosis","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.10.010_bib39","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2337\/db09-0349","article-title":"Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice","volume":"58","author":"Tu","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.kint.2018.10.010_bib40","doi-asserted-by":"crossref","first-page":"e17090","DOI":"10.1371\/journal.pone.0017090","article-title":"Effect of myostatin depletion on weight gain, hyperglycemia, and hepatic steatosis during five months of high-fat feeding in mice","volume":"6","author":"Burgess","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.10.010_bib41","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/ki.1992.83","article-title":"Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis","volume":"41","author":"Border","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.010_bib42","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1161\/ATVBAHA.107.161224","article-title":"Chemokines in vascular dysfunction and remodeling","volume":"28","author":"Schober","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2018.10.010_bib43","doi-asserted-by":"crossref","first-page":"H987","DOI":"10.1152\/ajpheart.01158.2008","article-title":"Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production","volume":"296","author":"Chen","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.kint.2018.10.010_bib44","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3389\/fphys.2017.00829","article-title":"The JNK signaling pathway in renal fibrosis","volume":"8","author":"Grynberg","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.kint.2018.10.010_bib45","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.cellsig.2007.07.002","article-title":"Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells","volume":"19","author":"Huang","year":"2007","journal-title":"Cell Sign"},{"key":"10.1016\/j.kint.2018.10.010_bib46","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/ki.2010.494","article-title":"Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease","volume":"79","author":"Verzola","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.010_bib47","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jcsm.12202","article-title":"Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction","volume":"8","author":"Enoki","year":"2017","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.kint.2018.10.010_bib48","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00787.2016","article-title":"Vasculopathy in the setting of cardiorenal syndrome: the roles of protein-bound 2 uremic toxins","volume":"313","author":"Guo","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.kint.2018.10.010_bib49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","article-title":"The chronic kidney disease-mineral bone disorder (CKD-MBD): advances in pathophysiology","volume":"100","author":"Hruska","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.kint.2018.10.010_bib50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.kint.2017.06.016","article-title":"The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease","volume":"93","author":"Williams","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.010_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.kint.2016.07.039","article-title":"Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease","volume":"91","author":"Sugatani","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.010_bib52","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrneph.2014.185","article-title":"Chronic kidney disease and premature ageing","volume":"10","author":"Kooman","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2018.10.010_bib53","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3945\/ajcn.112.036418","article-title":"Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy","volume":"97","author":"Kovesdy","year":"2013","journal-title":"Am J Cl Nutr"},{"key":"10.1016\/j.kint.2018.10.010_bib54","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0272-6386(98)70148-9","article-title":"Malnutrition, cardiac disease, and mortality: an integrated point of view","volume":"32","author":"Bergstr\u00f6m","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2018.10.010_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2215\/CJN.12541213","article-title":"Progressive inflammation and wasting in patients with ESRD","volume":"9","author":"Kaysen","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.10.010_bib56","first-page":"395","article-title":"A\u00a0simple protein-energy wasting score predicts survival in maintenance hemodialysis patients","volume":"24","author":"Moreau-Gaudry","year":"2014","journal-title":"J\u00a0Ren Nutr"},{"issue":"suppl","key":"10.1016\/j.kint.2018.10.010_bib57","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/sj.ki.5001969","article-title":"Inflammation and wasting in chronic kidney disease: partners in crime","volume":"104","author":"Avesani","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.010_bib58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ajcn\/80.2.299","article-title":"Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients","volume":"80","author":"Kalantar-Zadeh","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.kint.2018.10.010_bib59","first-page":"208","article-title":"Proteolytic mechanisms, not malnutrition, cause loss of muscle mass in kidney failure","volume":"16","author":"Mitch","year":"2006","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.kint.2018.10.010_bib60","first-page":"149","article-title":"Effect of uremia on structure and function of immune system","volume":"22","author":"Vaziri","year":"2012","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.kint.2018.10.010_bib61","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ki.2012.440","article-title":"The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease","volume":"83","author":"Anders","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.010_bib62","doi-asserted-by":"crossref","first-page":"168407","DOI":"10.1155\/2014\/168407","article-title":"Inflammation based regulation of cancer cachexia","volume":"2014","author":"Onesti","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.kint.2018.10.010_bib63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10409238.2013.857291","article-title":"Signaling pathways controlling skeletal muscle mass","volume":"49","author":"Egerman","year":"2014","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.kint.2018.10.010_bib64","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2018.10.010_bib65","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1681\/ASN.2014070714","article-title":"Cause of death in patients with reduced kidney function","volume":"26","author":"Thompson","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.10.010_bib66","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ndt\/15.7.953","article-title":"Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome)","volume":"15","author":"Stenvinkel","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.10.010_bib67","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0894-0959.2004.17606.x","article-title":"Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure","volume":"17","author":"Kalantar-Zadeh","year":"2004","journal-title":"Semin Dial"},{"issue":"suppl 3","key":"10.1016\/j.kint.2018.10.010_bib68","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1177\/089686080102103S27","article-title":"Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients","volume":"21","author":"Stenvinkel","year":"2001","journal-title":"Perit Dial Int J"},{"key":"10.1016\/j.kint.2018.10.010_bib69","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/ndt\/gfh891","article-title":"Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients","volume":"20","author":"Wang","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.10.010_bib70","first-page":"204","article-title":"Therapeutics targeting persistent inflammation in chronic kidney disease","volume":"167","author":"Machowska","year":"2016","journal-title":"Transl Res J Lab Clin Med"},{"key":"10.1016\/j.kint.2018.10.010_bib71","first-page":"254","article-title":"Latest consensus and update on protein-energy wasting in chronic kidney disease","volume":"18","author":"Obi","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.kint.2018.10.010_bib72","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1053\/j.ajkd.2006.05.029","article-title":"Effect of bicarbonate on muscle protein in patients receiving hemodialysis","volume":"48","author":"L\u00f6fberg","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2018.10.010_bib73","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1525-139X.2010.00763.x","article-title":"Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease","volume":"23","author":"Siew","year":"2010","journal-title":"Semin Dial"},{"key":"10.1016\/j.kint.2018.10.010_bib74","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/ki.2015.247","article-title":"Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis","volume":"88","author":"Garibotto","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.010_bib75","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/ndt\/gft435","article-title":"Insulin resistance in chronic kidney disease: new lessons from experimental models","volume":"29","author":"Koppe","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.10.010_bib76","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1152\/ajpendo.2002.282.1.E107","article-title":"Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation","volume":"282","author":"Ikizler","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.kint.2018.10.010_bib77","doi-asserted-by":"crossref","first-page":"E658","DOI":"10.1152\/ajpendo.00444.2003","article-title":"Coordinated increase in albumin, fibrinogen, and muscle protein synthesis during hemodialysis: role of cytokines","volume":"286","author":"Raj","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.kint.2018.10.010_bib78","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.ki.5001570","article-title":"Peripheral tissue release of interleukin-6 in patients with chronic kidney diseases: effects of end-stage renal disease and microinflammatory state","volume":"70","author":"Garibotto","year":"2006","journal-title":"Kidney Int"},{"issue":"22","key":"10.1016\/j.kint.2018.10.010_bib79","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95185","article-title":"Systemic inflammation is associated with exaggerated skeletal muscle protein catabolism in maintenance hemodialysis patients","volume":"2","author":"Deger","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.kint.2018.10.010_bib80","first-page":"352","article-title":"Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I receptor is decreased in sedentary chronic hemodialysis patients Kidney","volume":"68","author":"Wang","year":"2005","journal-title":"Int"},{"key":"10.1016\/j.kint.2018.10.010_bib81","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1096\/fj.10-176917","article-title":"Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease","volume":"25","author":"Zhang","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2018.10.010_bib82","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1074\/jbc.M115.641514","article-title":"Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia","volume":"290","author":"Silva","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2018.10.010_bib83","first-page":"10","article-title":"Relationship between blood myostatin levels and kidney function: Shimane CoHRE Study","volume":"26","author":"Yano","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.10.010_bib84","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.kint.2017.06.019","article-title":"Identifying early pathogenic events during vascular calcification in uremic rats","volume":"92","author":"Hortells","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.010_bib85","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/ndt\/gfw472","article-title":"FSTL3 is increased in renal dysfunction","volume":"32","author":"Kralisch","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.10.010_bib86","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2215\/CJN.10511110","article-title":"Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival","volume":"6","author":"Miyamoto","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.10.010_bib87","doi-asserted-by":"crossref","first-page":"7635459","DOI":"10.1155\/2017\/7635459","article-title":"Modulation of myostatin\/hepatocyte growth factor balance by different hemodialysis modalities","volume":"2017","author":"Esposito","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.kint.2018.10.010_bib88","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/ndt\/gfx342","article-title":"The effect of high-volume online haemodiafiltration on nutritional status and body composition: the ProtEin Stores prEservaTion (PESET) study","volume":"33","author":"Molina","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.10.010_bib89","doi-asserted-by":"crossref","first-page":"R461","DOI":"10.1152\/ajpregu.00030.2018","article-title":"Relationship between intermuscular adipose tissue infiltration and myostatin before and after aerobic exercise training","volume":"315","author":"Konopka","year":"2018","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.kint.2018.10.010_bib90","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/j.ajkd.2014.07.015","article-title":"Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial","volume":"65","author":"Greenwood","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2018.10.010_bib91","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MNH.0000000000000165","article-title":"The role of exercise training in the management of chronic kidney disease","volume":"24","author":"Howden","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2018.10.010_bib92","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1681\/ASN.2017010020","article-title":"Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial","volume":"29","author":"Ikizler","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"23","key":"10.1016\/j.kint.2018.10.010_bib93","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13525","article-title":"Effect of myostatin deletion on cardiac and microvascular function","volume":"5","author":"Butcher","year":"2017","journal-title":"Physiol Rep"},{"key":"10.1016\/j.kint.2018.10.010_bib94","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3389\/fphys.2017.00541","article-title":"The effect of resistance exercise on inflammatory and myogenic markers in patients with chronic kidney disease","volume":"8","author":"Watson","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.kint.2018.10.010_bib95","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13105-012-0183-x","article-title":"Myostatin expression is regulated by underfeeding and neonatal programming in rats","volume":"69","author":"Carneiro","year":"2013","journal-title":"J\u00a0Physiol Biochem"},{"key":"10.1016\/j.kint.2018.10.010_bib96","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.domaniend.2003.10.001","article-title":"Nutrient supply enhances both IGF-I and MSTN mRNA levels in chicken skeletal muscle","volume":"26","author":"Guernec","year":"2004","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.kint.2018.10.010_bib97","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1123\/ijsnem.16.2.153","article-title":"Increased myostatin synthesis in rat gastrocnemius muscles under high-protein diet","volume":"16","author":"Nakazato","year":"2006","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"10.1016\/j.kint.2018.10.010_bib98","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1152\/japplphysiol.00504.2010","article-title":"Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice","volume":"109","author":"Allen","year":"2010","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.kint.2018.10.010_bib99","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1677\/joe.0.1760425","article-title":"Prolonged underfeeding of sheep increases myostatin and myogenic regulatory factor Myf-5 in skeletal muscle while IGF-1 and myogenin are repressed","volume":"176","author":"Jeanplong","year":"2003","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.kint.2018.10.010_bib100","first-page":"137","article-title":"Acute dietary protein intake restriction is associated with changes in myostatin expression after a single bout of resistance exercise in healthy young men","volume":"144","author":"Snijders","year":"2014","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.kint.2018.10.010_bib101","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.kint.2016.07.029","article-title":"The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro\/adipogenic progenitor cells in chronic kidney disease","volume":"91","author":"Dong","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.010_bib102","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.kint.2016.02.002","article-title":"Ligand trap for the Activin Type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease","volume":"89","author":"Agapova","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.010_bib103","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0006-291X(02)02953-4","article-title":"Inhibition of MSTN in adult mice increases skeletal muscle mass and strength","volume":"300","author":"Whittemore","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.kint.2018.10.010_bib104","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","article-title":"Acute inhibition of MSTN-family proteins preserves skeletal muscle in mouse models of cancer cachexia","volume":"391","author":"Benny Klimek","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.kint.2018.10.010_bib105","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.kint.2018.10.010_bib106","doi-asserted-by":"crossref","first-page":"R716","DOI":"10.1152\/ajpregu.00121.2011","article-title":"Antibody-directed MSTN inhibition enhances muscle mass and function in tumor-bearing mice","volume":"301","author":"Murphy","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.kint.2018.10.010_bib107","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/ijc.29930","article-title":"Complete reversal of muscle wasting in experimental cancer cachexia: additive effects of activin type II receptor inhibition and \u03b2-2 agonist","volume":"138","author":"Toledo","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.kint.2018.10.010_bib108","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","article-title":"STEADY Group MSTN antibody (LY2495655) in older weak fallers: a proof-of-concept, randomized, phase 2 trial","volume":"3","author":"Becker","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2018.10.010_bib109","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1096\/fj.04-2796com","article-title":"MSTN propeptide-mediated amelioration of dystrophic pathophysiology","volume":"19","author":"Bogdanovich","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2018.10.010_bib110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.kint.2018.10.010_bib111","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mus.23539","article-title":"A\u00a0single ascending-dose study of muscle regulator ACE-031 in healthy volunteers","volume":"47","author":"Attie","year":"2013","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.kint.2018.10.010_bib112","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/mus.25268","article-title":"MSTN inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: results of a randomized, placebo-controlled clinical trial","volume":"55","author":"Campbell","year":"2017","journal-title":"Muscle Nerve"},{"issue":"suppl","key":"10.1016\/j.kint.2018.10.010_bib113","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1200\/jco.2012.30.15_suppl.2516","article-title":"Safety of the anti-MSTN monoclonal antibody LY2495655 in healthy subjects and patients with advanced cancer [abstract 2516]","volume":"30","author":"Jameson","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.kint.2018.10.010_bib114","first-page":"62","article-title":"A\u00a0phase 2 randomized study investigating the efficacy and safety of MSTN Antibody LY2495655 versus placebo in patients undergoing elective total hip arthroplasty","volume":"5","author":"Woodhouse","year":"2016","journal-title":"J\u00a0Frailty Aging"},{"key":"10.1016\/j.kint.2018.10.010_bib115","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jgs.14927","article-title":"Treatment of sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study","volume":"65","author":"Rooks","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.kint.2018.10.010_bib116","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1212\/WNL.0000000000001070","article-title":"Treatment of sporadic inclusion body myositis with bimagrumab","volume":"83","author":"Amato","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.kint.2018.10.010_bib117","first-page":"90","article-title":"Long-term efficacy and safety of bimagrumab in inclusion body myositis: 2 years results","volume":"15S","author":"Amato","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.kint.2018.10.010_bib118","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1038\/s41598-018-20524-9","article-title":"Blocking extracellular activation of MSTN as a strategy for treating muscle wasting","volume":"8","author":"Pirruccello-Straub","year":"2018","journal-title":"Sci Rep"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818307774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818307774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:52:38Z","timestamp":1758761558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818307774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0085253818307774"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.10.010","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging role of myostatin and its inhibition in the setting of chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}